Cargando…

Circulating dendritic cell levels identify high-risk stage II-III melanoma patients: a potential role as additional prognostic marker

Detalles Bibliográficos
Autores principales:	Stucci, Stefania, Tucci, Marco, Passarelli, Anna, Mannavola, Francesco, Felici, Claudia, Giudice, Giuseppe, Silvestris, Franco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315279/ http://dx.doi.org/10.1186/1479-5876-13-S1-P14

Ejemplares similares

Immune System Evasion as Hallmark of Melanoma Progression: The Role of Dendritic Cells
por: Tucci, Marco, et al.
Publicado: (2019)

Exosomes in melanoma: a role in tumor progression, metastasis and impaired immune system activity
por: Tucci, Marco, et al.
Publicado: (2018)

Immune system and melanoma biology: a balance between immunosurveillance and immune escape
por: Passarelli, Anna, et al.
Publicado: (2017)

Tumor-derived exosomes promote the in vitro osteotropism of melanoma cells by activating the SDF-1/CXCR4/CXCR7 axis
por: Mannavola, Francesco, et al.
Publicado: (2019)

Circulating tumor cells from melanoma patients show phenotypic plasticity and metastatic potential in xenograft NOD.CB17 mice
por: Felici, Claudia, et al.
Publicado: (2022)

The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma
por: Marco, Tucci, et al.
Publicado: (2019)

Extracellular Vesicles and Epigenetic Modifications Are Hallmarks of Melanoma Progression
por: Mannavola, Francesco, et al.
Publicado: (2019)

Dendritic cell-derived exosomes (Dex) are potential biomarkers of response to Ipilimumab in metastatic melanoma
por: Stucci, Stefania, et al.
Publicado: (2015)

Dual-procedural separation of CTCs in cutaneous melanoma provides useful information for both molecular diagnosis and prognosis
por: Tucci, Marco, et al.
Publicado: (2020)

Non-Melanoma Skin Cancers: Biological and Clinical Features
por: Cives, Mauro, et al.
Publicado: (2020)

A Lipidomic Approach to Identify Potential Biomarkers in Exosomes From Melanoma Cells With Different Metastatic Potential
por: Lobasso, Simona, et al.
Publicado: (2021)

Revisiting the Role of Exosomes in Colorectal Cancer: Where Are We Now?
por: Mannavola, Francesco, et al.
Publicado: (2019)

Dissection of major cancer gene variants in subsets of circulating tumor cells in advanced breast cancer
por: D’Oronzo, Stella, et al.
Publicado: (2019)

Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology
por: Palmirotta, Raffaele, et al.
Publicado: (2018)

Liquid Biopsy as a Tool Exploring in Real-Time Both Genomic Perturbation and Resistance to EGFR Antagonists in Colorectal Cancer
por: Internò, Valeria, et al.
Publicado: (2020)

Large Extracellular Vesicles—A New Frontier of Liquid Biopsy in Oncology
por: Pezzicoli, Gaetano, et al.
Publicado: (2020)

The ATM Gene in Breast Cancer: Its Relevance in Clinical Practice
por: Stucci, Luigia Stefania, et al.
Publicado: (2021)

Clinical trials with MRNA electroporated dendritic cells for stage III/IV melanoma patients
por: Wilgenhof, Sofie, et al.
Publicado: (2015)

Feasibility of personalized circulating tumor DNA detection in stage II and III melanoma
por: Brunsgaard, Elise K., et al.
Publicado: (2023)

Identification of new prognostic biomarkers for Stage III metastatic melanoma patients
por: Kakavand, Hojabr, et al.
Publicado: (2013)

Cytokine Overproduction, T-Cell Activation, and Defective T-Regulatory Functions Promote Nephritis in Systemic Lupus Erythematosus
por: Tucci, Marco, et al.
Publicado: (2010)

Immune-related adverse events during anticancer immunotherapy: Pathogenesis and management
por: Stucci, Stefania, et al.
Publicado: (2017)

Lymph Node Ratio: Is It an Independent Prognostic Factor for Stage III Cutaneous Melanoma?
por: Salari, Abolfazl, et al.
Publicado: (2018)

Prognostic and Predictive Biomarkers in Stage III Melanoma: Current Insights and Clinical Implications
por: Tonella, Luca, et al.
Publicado: (2021)

SNPs in predicting clinical efficacy and toxicity of chemotherapy: walking through the quicksand
por: Palmirotta, Raffaele, et al.
Publicado: (2018)

Presence of Circulating Tumor Cells Predates Imaging Detection of Relapse in Patients with Stage III Melanoma
por: Lucci, Anthony, et al.
Publicado: (2023)

Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients
por: Boudewijns, Steve, et al.
Publicado: (2016)

DNA ploidy and S-phase in primary malignant melanoma as prognostic factors for stage III disease.
por: Karlsson, M., et al.
Publicado: (1993)

Prognostic Factors of Melanoma Patients with Satellite or In-Transit Metastasis at the Time of Stage III Diagnosis
por: Weide, Benjamin, et al.
Publicado: (2013)

pIL6-TRAIL-engineered umbilical cord mesenchymal/stromal stem cells are highly cytotoxic for myeloma cells both in vitro and in vivo
por: Cafforio, Paola, et al.
Publicado: (2017)

Circulating tumor DNA predicts survival in patients with resected high-risk stage II/III melanoma
por: Lee, R J, et al.
Publicado: (2018)

Thrombocytosis as a prognostic marker in stage III and IV serous ovarian cancer
por: Digklia, Antonia, et al.
Publicado: (2014)

Combination of immunotherapy and other targeted therapies in advanced cutaneous melanoma
por: Marconcini, Riccardo, et al.
Publicado: (2021)

Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer
por: Chen, Gong, et al.
Publicado: (2021)

The cost of unresectable stage III or stage IV melanoma in Italy
por: Maio, Michele, et al.
Publicado: (2012)

Postoperative, but not preoperative, inflammation-based prognostic markers are prognostic factors in stage III colorectal cancer patients
por: Yasui, Kohei, et al.
Publicado: (2020)

Immune-related Adverse Events of Dendritic Cell Vaccination Correlate With Immunologic and Clinical Outcome in Stage III and IV Melanoma Patients
por: Boudewijns, Steve, et al.
Publicado: (2016)

Immunological responses to adjuvant vaccination with combined CD1c(+) myeloid and plasmacytoid dendritic cells in stage III melanoma patients
por: Bloemendal, Martine, et al.
Publicado: (2021)

Prognostic significance of perioperative tumor marker levels in stage II/III gastric cancer
por: Suenaga, Yasuhito, et al.
Publicado: (2019)

Superficial and deep lymph node dissection for stage III cutaneous melanoma: clinical outcome and prognostic factors
por: Mozzillo, Nicola, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ak7hlipcg1na38hmkcr32pm31a